MONDAY, Oct. 10, 2022 (HealthDay News) – While the United States has recently ordered a $290 million supply of a drug meant to treat radiation sickness, federal health officials say that’s not cause for alarm. It’s coincidental that the order of Nplate, made by pharmaceutical company Amgen, comes just as Russian President Vladimir Putin is…  read on >  read on >

Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma, hardens the skin and affects internal organs, but no approved treatment for it exists. So, the research team from the University of Michigan and University of…  read on >  read on >

Pancreatic cancer is often fatal, but a molecular test that can accurately distinguish benign cysts from those that could become cancerous may be a key to saving lives. Researchers tested the technology — called PancreaSeq — to see if it could work in a clinical setting and found success. “Based on the results of this…  read on >  read on >

The U.S. Environmental Protection Agency (EPA) has taken a major step to curb the largest remaining source of airborne lead pollution. The agency has proposed a so-called endangerment finding that aircraft that use leaded fuel cause or contribute to pollution that could harm public health and welfare. A majority of aircraft that use leaded fuel…  read on >  read on >

Firearm sales in the United States broke records at the beginning of the COVID-19 pandemic. Now, researchers have found that firearm injuries to children also increased during the pandemic’s first two years compared to the preceding year. “We experienced an increase in pediatric firearm-related injuries in spite of a decrease in total pediatric emergency department…  read on >  read on >